Cross-linked fibrin degradation products by leukocyte elastase (e-XDP)
Madoiwa, S.
Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 65-70
2011
ISSN/ISBN: 0047-1860 PMID: 21766524 Document Number: 655782
Document emailed within 1 workday
Related Documents
Francis, C.W.; Marder, V.J. 1986: Degradation of cross-linked fibrin by human leukocyte proteases Journal of Laboratory and Clinical Medicine 107(4): 342-352Kamitsuji, H.; Matsunaga, K.; Taira, K.; Nakajima, M.; Whitworth, J.A.; Kincaid-Smith, P. 1988: Urinary cross-linked fibrin degradation products in glomerular disease with crescents Clinical Nephrology 29(3): 124-128
Vorlová, Z.; Dyr, I.E. 1979: Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test) Folia Haematologica 106(5-6): 967-970
Tikhonova, T.V.; Larionova, N.I.; Gladysheva, I.P.; Kazanskaia, N.F. 1993: Bowman-Birk soy inhibitor as an affinity ligand for isolating leukocyte elastase. Inhibition of elastin hydrolysis, catalyzed by leukocyte elastase Biokhimiia 58(11): 1669-1676
Kuroso, K.; Fujimaki, M. 1989: Fibrin/fibrinogen degradation products (FDP) Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 892-895
Fujimaki, M.; Ikematsu, S.; Kato, M. 1973: Fibrinogen and fibrin degradation products Rinsho Byori. Japanese Journal of Clinical Pathology 21(1): 31-36
Pstruzinová, H.; Rovenská, A.; Goderová, Z.; Kristan, M. 1980: Examination of fibrin degradation products in cirrhosis of liver Casopis Lekaru Ceskych 119(1): 7-11
Tomura, S.; Ideura, T.; Ida, T.; Osaka, Y.; Kuriyama, R.; Abe, T.; Takeuchi, J. 1979: Renal vein fibrin degradation products (FDP's) in glomerulonephritis Clinical Nephrology 12(6): 248-253
Khristov, V.; Apostolov, P.; Stamenova, T. 1979: Fibrin degradation products in the urine in diabetic nephropathy Vutreshni Bolesti 18(4): 32-36
Isobe, J.; Hamai, Y.; Taharaguchi, T.; Watanabe, H.; Kusumoto, M.; Saito, S. 1977: Studies on latex agglutination test for fibrin degradation products Rinsho Byori. Japanese Journal of Clinical Pathology 25(10): 843-847
Sasinka, M.; Plenta, I.; Páleníková, O.; Pavlovic, M.; Getlík, A.; Kaiserová, E. 1979: Analysis of fibrin-degradation products in the diagnosis of glomerulonephritis in children Ceskoslovenska Pediatrie 34(4): 202-204
Schifreen, R.S.; Cembrowski, G.S.; Campbell, D.C.; Craig, A.R.; Demyanovich, N.D.; Jurga-Hall, P.A.; Reider, M.C.; Schwartz, M.W.; Tuhy, P.M.; Waller, S.J. 1985: A quantitative automated immunoassay for fibrinogen/fibrin degradation products Clinical Chemistry 31(9): 1468-1473
Weise, M.; Schwabe, G.; Neubüser, D. 1979: Fibrin and fibrinogen degradation products and other urinary proteins during eclampsia Minerva Medica 70(43): 2945-2949
Svanberg, L.; Astedt, B.; Gynning, I.; Nilsson, I.M. 1973: Fibrin degradation products during postoperative radiotherapy of ovarian carcinoma Acta Obstetricia et Gynecologica Scandinavica 52(2): 141-145
Sen, D.K.; Sarin, G.S. 1981: Assay of fibrin degradation products in human aqueous humour Indian Journal of Ophthalmology 29(2): 87-89
Mogila, T.V. 1980: Fibrinogen and fibrin degradation products in hemorrhagic fever and renal syndrome Klinicheskaia Meditsina 58(5): 57-60
Kolodie, L.; Phelipp, X.; Baccard, C. 1980: Study of the fibrin degradation products in the synovial fluid of rheumatological diseases La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 56(17-18): 832-836
Bouvier, C.A.; Aguercif, M.; Ritschard, J. 1974: Search for fibrin degradation products following pulmonary embolism. Preliminary communication Schweizerische Medizinische Wochenschrift 104(4): 153
Utetleuov, B. 1977: Fibrin/figrinogen degradation products in the urine in children with glomerulonephritis and pyelonephritis Pediatriia 2: 22-24
Carroll, R.C.; Lockhart, M.S.; Taylor, F.B. 1984: Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma Journal of Laboratory and Clinical Medicine 103(5): 695-703